Medigene Ag Is A Biotechnology Company Based In Planegg Martinsriedgermanyspecializing In Immuno Oncologyfounded In 1994The Company Focuses On Developing T Cell Receptortcrguided Therapies To Treat Cancermedigene Operates Subsidiaries In The U Sand Asia And Is Publicly Listed On The Frankfurt Stock Exchange The Company Utilizes Its Proprietary End To Ende2Eplatform To Create Tcr Based Immunotherapiesthis Platform Integrates Technologies For Tcr Generationoptimizationand Product Enhancementemphasizing Specificitysensitivityand Safetymedigene S Product Offerings Include Tcr T Cell Therapiestcr Nk Cell Therapiesand Tcr T Cell Engagersnotable Lead Candidates Include Mdg1015Targeting Ny Eso 1 Lage 1Aand Mdg2011Which Targets The Kras G12V Mutationmedigene Aims To Expand Its Pipeline Of Precision Targeted Therapies For Solid Tumorsaddressing Significant Medical Needs In Cancer Treatment
No conferences found for this company.
| Company Name | Medigene Ag |
| Country |
Germany
|
| Address | N/A |
| Telephone | N/A |
| N/A |
